26th Hong Kong Medical Forum

14 May 2022 - 15 May 2022

Secondary immunodeficiency common yet underdiagnosed and undertreated in HK

07 Jun 2022 by

Local data presented at the 26^th HKMF indicates that secondary immunodeficiency (SID), a common disease that can be treated with immunoglobulin (Ig) replacement therapy, is underdiagnosed and undertreated in Hong Kong.

Secondary immunodeficiency common yet underdiagnosed and undertreated in HK

07 Jun 2022

Adding spironolactone or sacubitril/valsartan to empagliflozin suggested for a wide spectrum of symptomatic HFpEF

27 May 2022 by

Spironolactone and sacubitril/valsartan are potential add-on therapies to empagliflozin for a wide spectrum of symptomatic heart failure with preserved ejection fraction (HFpEF), according to an evidence-based treatment algorithm presented at the 26^th Hong Kong Medical Forum.

Adding spironolactone or sacubitril/valsartan to empagliflozin suggested for a wide spectrum of symptomatic HFpEF

27 May 2022

COVID-19 vaccine booster efficacy: What do new HK data show?

23 May 2022 by

A booster dose of the mRNA-based BNT162b2 vaccine provides more robust antibody responses to SARS-CoV-2, including the Omicron BA.1 and BA.2 variants, than the inactivated CZ02 vaccine, but three doses of either vaccine are equally effective in reducing the risk of severe or fatal COVID-19, according to new local data presented at the 26th Hong Kong Medical Forum (HKMF).

COVID-19 vaccine booster efficacy: What do new HK data show?

23 May 2022